ALBEMARLE ($ALB) posted quarterly earnings results on Wednesday, July 30th. The company reported earnings of $0.11 per share, beating estimates of -$0.83 by $0.94. The company also reported revenue of $1,329,990,000, beating estimates of $1,226,924,376 by $103,065,624.
You can see Quiver Quantitative's $ALB stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ALBEMARLE Hedge Fund Activity
We have seen 327 institutional investors add shares of ALBEMARLE stock to their portfolio, and 445 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 2,331,694 shares (-36.0%) from their portfolio in Q1 2025, for an estimated $167,928,601
- FRANKLIN RESOURCES INC added 2,259,480 shares (+86.9%) to their portfolio in Q1 2025, for an estimated $162,727,749
- BAILLIE GIFFORD & CO removed 1,736,466 shares (-81.4%) from their portfolio in Q1 2025, for an estimated $125,060,281
- BLACKROCK, INC. removed 1,635,004 shares (-15.6%) from their portfolio in Q1 2025, for an estimated $117,752,988
- SQUAREPOINT OPS LLC added 687,356 shares (+785.5%) to their portfolio in Q1 2025, for an estimated $49,503,379
- BARROW HANLEY MEWHINNEY & STRAUSS LLC removed 663,917 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $47,815,302
- INVESCO LTD. added 606,958 shares (+29.0%) to their portfolio in Q1 2025, for an estimated $43,713,115
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ALBEMARLE Congressional Stock Trading
Members of Congress have traded $ALB stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $ALB stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 1 purchase worth up to $50,000 on 04/07 and 2 sales worth up to $100,000 on 05/12, 02/24.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 02/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ALBEMARLE Analyst Ratings
Wall Street analysts have issued reports on $ALB in the last several months. We have seen 0 firms issue buy ratings on the stock, and 4 firms issue sell ratings.
Here are some recent analyst ratings:
- Baird issued a "Underperform" rating on 07/29/2025
- UBS issued a "Sell" rating on 07/11/2025
- Morgan Stanley issued a "Underweight" rating on 05/06/2025
- Piper Sandler issued a "Underweight" rating on 02/20/2025
To track analyst ratings and price targets for ALBEMARLE, check out Quiver Quantitative's $ALB forecast page.
ALBEMARLE Price Targets
Multiple analysts have issued price targets for $ALB recently. We have seen 14 analysts offer price targets for $ALB in the last 6 months, with a median target of $65.0.
Here are some recent targets:
- Ben Kallo from Baird set a target price of $60.0 on 07/29/2025
- Michael Sison from Wells Fargo set a target price of $75.0 on 07/14/2025
- Scott Schoenhaus from Keybanc set a target price of $87.0 on 07/14/2025
- Joshua Spector from UBS set a target price of $57.0 on 07/11/2025
- Vincent Andrews from Morgan Stanley set a target price of $58.0 on 05/06/2025
- Ben Isaacson from Scotiabank set a target price of $65.0 on 05/06/2025
- Jeffrey Zekauskas from JP Morgan set a target price of $60.0 on 05/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
